Free Trial

Rafferty Asset Management LLC Boosts Stock Position in The Allstate Co. (NYSE:ALL)

Allstate logo with Finance background

Rafferty Asset Management LLC raised its position in shares of The Allstate Co. (NYSE:ALL - Free Report) by 4.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 93,422 shares of the insurance provider's stock after purchasing an additional 3,900 shares during the quarter. Rafferty Asset Management LLC's holdings in Allstate were worth $18,011,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the stock. VSM Wealth Advisory LLC purchased a new stake in Allstate in the 4th quarter worth approximately $25,000. Twin Tree Management LP purchased a new stake in Allstate in the 4th quarter worth approximately $27,000. Vision Financial Markets LLC purchased a new stake in Allstate in the 4th quarter worth approximately $29,000. Hopwood Financial Services Inc. purchased a new stake in Allstate in the 4th quarter worth approximately $29,000. Finally, Kapitalo Investimentos Ltda purchased a new stake in Allstate in the 4th quarter worth approximately $29,000. 76.47% of the stock is currently owned by institutional investors.

Allstate Trading Up 0.4%

Shares of NYSE ALL traded up $0.84 during mid-day trading on Monday, reaching $209.90. The company had a trading volume of 1,029,866 shares, compared to its average volume of 1,615,153. The business's 50-day moving average is $199.48 and its 200-day moving average is $195.75. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42. The Allstate Co. has a 52 week low of $156.66 and a 52 week high of $212.91. The stock has a market cap of $55.59 billion, a price-to-earnings ratio of 12.35, a price-to-earnings-growth ratio of 1.01 and a beta of 0.32.

Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $3.53 EPS for the quarter, missing the consensus estimate of $3.98 by ($0.45). The firm had revenue of $14.30 billion for the quarter, compared to analysts' expectations of $16.41 billion. Allstate had a net margin of 7.28% and a return on equity of 28.20%. The business's quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $5.13 EPS. Equities analysts expect that The Allstate Co. will post 18.74 earnings per share for the current year.

Allstate declared that its board has initiated a stock repurchase plan on Wednesday, February 26th that authorizes the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization authorizes the insurance provider to buy up to 3% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board of directors believes its shares are undervalued.

Allstate Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Monday, March 10th were paid a dividend of $1.00 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $4.00 annualized dividend and a dividend yield of 1.91%. This is a positive change from Allstate's previous quarterly dividend of $0.92. Allstate's dividend payout ratio (DPR) is currently 27.32%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on ALL shares. Raymond James reaffirmed a "strong-buy" rating and set a $250.00 price objective (up from $240.00) on shares of Allstate in a report on Monday, May 5th. BMO Capital Markets reaffirmed an "outperform" rating on shares of Allstate in a report on Friday. Keefe, Bruyette & Woods increased their price objective on shares of Allstate from $228.00 to $235.00 and gave the company an "outperform" rating in a report on Wednesday, May 7th. Wells Fargo & Company cut their price objective on shares of Allstate from $200.00 to $197.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Finally, Morgan Stanley increased their price objective on shares of Allstate from $225.00 to $235.00 and gave the company an "overweight" rating in a report on Tuesday, May 6th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Allstate has a consensus rating of "Moderate Buy" and a consensus price target of $225.20.

Get Our Latest Stock Analysis on ALL

Allstate Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Stories

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Should You Invest $1,000 in Allstate Right Now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines